- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chongqing Genrix Biopharmaceutical (688443)
Chongqing Genrix Biopharmaceutical stock price live, this page displays SS 688443 stock exchange data. View the 688443 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chongqing Genrix Biopharmaceutical real time stock price chart below.
What Is the Chongqing Genrix Biopharmaceutical Stock Price Today?
The Chongqing Genrix Biopharmaceutical stock price today is 30.55.
What Is the Stock Symbol for Chongqing Genrix Biopharmaceutical?
The stock symbol for Chongqing Genrix Biopharmaceutical is ""688443.""
What Stock Exchange Does Chongqing Genrix Biopharmaceutical Trade On?
Chongqing Genrix Biopharmaceutical is listed and trades on the Shanghai stock exchange.
Is Chongqing Genrix Biopharmaceutical a Good Stock to Buy?
Determining whether Chongqing Genrix Biopharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688443 quote. (ISIN: CNE100006KG8)
What Is the Chongqing Genrix Biopharmaceutical Stock Price Today?
The Chongqing Genrix Biopharmaceutical stock price today is 30.55.
What Is the Stock Symbol for Chongqing Genrix Biopharmaceutical?
The stock symbol for Chongqing Genrix Biopharmaceutical is ""688443.""
What Stock Exchange Does Chongqing Genrix Biopharmaceutical Trade On?
Chongqing Genrix Biopharmaceutical is listed and trades on the Shanghai stock exchange.
Is Chongqing Genrix Biopharmaceutical a Good Stock to Buy?
Determining whether Chongqing Genrix Biopharmaceutical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688443 quote. (ISIN: CNE100006KG8)
Shanghai
Currency in CNY
30.55
-0.35(-1.13%)
Closed·
Fair Value
An estimate of a Chongqing Genrix Biopharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.48
31.12
52 wk Range
22.58
37.88
688443 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
688443 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Chongqing Genrix Biopharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.4831.12
52 wk Range
22.5837.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688443 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Chongqing Genrix Biopharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
40.00
Upside
+30.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Chongqing Genrix Biopharmaceutical Company Profile
Chongqing Genrix Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China. It develops GR1501, a monoclonal antibody for the treatment of axial spondylarthritis; GR1801, an anti-rabies virus G protein bispecific antibody; GR1802, an anti-IL-4Ra monoclonal antibody; GR1603, a monoclonal antibody for systemic lupus erythematosus; GR2002 an anti-TSLP bispecific antibody; WM1R3, a family receptor bispecific antibody; GR2001, a monoclonal antibody; GR2201, a monoclonal antibody for VZV infection; GR1803, a bispecific antibody for multiple myeloma; GR1901, a bispecific antibody; WM202 a bispecific antibody; WM215, a single-domain antibody; GR1401, an anti-EGFR monoclonal antibody; and GR1405 an anti-PD-L1 monoclonal antibody. The company was founded in 2015 and is based in Chongqing, China.
Compare 688443 to Peers and Sector
Metrics to compare | 688443 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688443PeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.5x | −17.6x | −0.7x | |
PEG Ratio | −2.20 | −0.21 | 0.00 | |
Price/Book | 6.1x | 6.8x | 2.6x | |
Price / LTM Sales | 148.4x | 21.4x | 3.4x | |
Upside (Analyst Target) | 30.9% | 10.0% | 35.5% | |
Fair Value Upside | Unlock | −17.5% | 3.3% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 40.00
(+30.93% Upside)
Earnings
Latest Release
Aug 29, 2025
EPS / Forecast
-0.46 / --
Revenue / Forecast
25.24M / --
FAQ
What Stock Exchange Does Chongqing Genrix Biopharmaceutical Trade On?
Chongqing Genrix Biopharmaceutical is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for Chongqing Genrix Biopharmaceutical?
The stock symbol for Chongqing Genrix Biopharmaceutical is "688443."
What Is the Chongqing Genrix Biopharmaceutical Market Cap?
As of today, Chongqing Genrix Biopharmaceutical market cap is 11.20B.
What Is Chongqing Genrix Biopharmaceutical's Earnings Per Share (TTM)?
The Chongqing Genrix Biopharmaceutical EPS (TTM) is -1.97.
When Is the Next Chongqing Genrix Biopharmaceutical Earnings Date?
Chongqing Genrix Biopharmaceutical will release its next earnings report on 26 Oct 2025.
From a Technical Analysis Perspective, Is 688443 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Chongqing Genrix Biopharmaceutical Stock Split?
Chongqing Genrix Biopharmaceutical has split 0 times.
How Many Employees Does Chongqing Genrix Biopharmaceutical Have?
Chongqing Genrix Biopharmaceutical has 793 employees.
What is the current trading status of Chongqing Genrix Biopharmaceutical (688443)?
As of 04 Oct 2025, Chongqing Genrix Biopharmaceutical (688443) is trading at a price of 30.55, with a previous close of 30.90. The stock has fluctuated within a day range of 30.48 to 31.12, while its 52-week range spans from 22.58 to 37.88.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.